Lelarge, V.
Capelle, R.
Oger, F. http://orcid.org/0000-0003-0006-5835
Mathieu, T.
Le Calvé, B. http://orcid.org/0009-0001-8745-1925
Article History
Received: 17 August 2023
Accepted: 17 January 2024
First Online: 6 February 2024
Competing interests
: The authors declare the following competing interests: T.M. is the founder of StarkAge Therapeutics which is developing therapy against senescent cells. T.M. and B.L.C. are stockholders of StarkAge Therapeutics. V.L. and R.C. are currently employed by StarkAge Therapeutics. FO no longer have a financial interest in the company.